When will the FDA approve Compass Pathways' COMP360 Psilocybin?
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Begins in 387 days · Jun 30, 12:00am EDT
Chance
Before Mar 1, 2027
49%
Before Mar 1, 2027
49%
Before July 2027
69%
â–¼ 6
Before July 2027
69%
â–¼ 6
Before October 2027
77%
Before October 2027
77%
2 more
Market Rules
Before Jan 1, 2027
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes. Sources from U.S. Food and Drug Administration., FDA, and Compass Pathways.
Timeline and payout
Market openMay 15, 2026 · 10:30pm EDT
Market closesAfter the outcome occurs
Projected payout30 minutes after closing
SeriesKXFDAAPPROVALDATECMPS
EventKXFDAAPPROVALDATECMPS-360
MarketKXFDAAPPROVALDATECMPS-360-27JAN01
Insider trading is prohibited
The following are prohibited from trading this contract:
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.